Andrea Neisser-Svae, Head of IBU Intensive Care & Emergency Medicine Octapharma Group

Our patients are critically ill patients that require immediate medical attention. Amongst the critical factors to take in consideration, high quality, safety, efficacy and tolerability products are of extreme importance.

Octapharma strives at developing the best emergency medicine products to treat patients in ICEM setting.

ICEM Portfolio

Tolerability and safety in plasma transfusion

Fast & safe restoration of coagulation balance


Safe coagulation control


Albumin – nature’s choice of colloid

Healthcare Professionals : Intensive Care and Emergency Medicine

Every day, physicians, nurses and paramedicus must take difficult and fast decisions in order to restore normal body functions inpatients requiring emergency medicine or admitted to intensive care. One key factor to take into consideration is the quality, safety, efficacy and tolerability of blood-derived products used to treat such patients.

 

Octapharma's Intensive Care & Emergency Medicine (ICEM) Portfolio comprises high-quality human plasma and protein products for stabilising blood circulation, restoring coagulation function, and preventing shock in critically ill or injured patients in intensive care and emergency settings. All are virus inactivated for utmost safety, and are proven to be fast-acting and effective with minimal adverse reactions.

Our Commitment to ICEM

As a specialist in developing and manufacturing plasma-derived products, Octapharma aims to develop the best emergency medicine products. Given the challenges of using blood components in ICEM, we have introduced a confidence-building concept in all our activities to support our ICU partners to find even more effective ways of using blood component therapies, thereby optimising safety and reducing both side effects and costs.

 

We support ICU teams through educational sessions in hospitals and scientific symsposiums at medical congresses. Such activities show our commitment to ICEM, and help us align our efforts with the needs of the medical community.